Lixte Biotechnology Holdings's total assets for Q were $2.67M, a decrease of -25.68% from the previous quarter. LIXT total liabilities were $421.46K for the fiscal quarter, a 70.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.